• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Boston Scientific 4Q Results

Jim Rogers

new user
Boston Scientific (BSX) reported a net loss of $615 million in the fourth quarter due to one-time income tax charge of $842 million. Adjusted earnings came in at $0.34 per share, which improved 13% vs. last year. MedSurg business grew 14% in the fourth quarter raking in $931 million. Check out the highlights: http://alph.st/bcdf4ce8